Teresa Petrella, MD, MHSc, FRCPC, discusses long-term data that inform the sequencing of immunotherapy and targeted therapies for frontline melanoma.
Health Professionals
7-Year Follow-up of ABC Trial: Ipilimumab/Nivolumab vs Nivolumab Alone in Melanoma Brain Metastases
As reported in The Lancet Oncology by Long et al, 7-year follow-up of the Australian phase II ABC trial showed continued benefit of ipilimumab/nivolumab vs nivolumab alone in patients with asymptomatic melanoma brain metastases.
Cost-of-Care Discussions Between Cancer Patients & Providers
Most physicians agree that patients should know how much they’re going to pay for treatment before deciding on a plan. According to a survey of breast cancer surgeons, 87 percent agreed with this. Yet, it’s only a minority of physicians who claim they have cost-of-care discussions with their patients.
AI diagnostic platform improves early detection of skin cancer
If detected early, the prognosis for skin cancer is excellent. An innovative full-body scanner linked to an AI diagnostic platform is set to help with early detection of melanoma. In just six minutes, it automatically scans a patient’s entire body, providing a risk assessment for each anomalous change found in the skin.